UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with obesity and type 2 diabetes that affects more than ...

Nov 13 (Reuters) - The U.S. Food and Drug Administration approved PTC Therapeutics' (PTCT.O), opens new tab gene therapy that ...

The genetic mutation that causes Huntington's disease (HD)—a devastating brain disease that disrupts mobility and diminishes ...

A simple blood test could soon predict which ovarian cancer patients will stop responding to their treatment, paving the way ...